NYSE CRTR Economy Event Watch the replay →
Global X Genomics & Biotechnology ETF
GNOM performance and flow charts
Performance
Flows
Historic performance and flows
Data as of June 12, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +4.86% | +12.44% | +7.73% | +47.34% | -2.60% | -46.66% |
| Flows | +$4M | +$6M | +$4M | -$4M | -$104M | +$8M |
Characteristics
The Global X Genomics & Biotechnology ETF is built to track the Solactive Genomics Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Strategy | Long Only |
| Provider | Global X |
| N° of holdings | 49 |
| Replication method | Direct (Physical) |
| Asset class | Equity |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | April 5, 2019 |
| ESG | No |
More data and info about GNOM on Trackinsight
Exposure
Data as of April 30, 2026Diversification
Total weight of top 15 holdings out of 49
Top 15 Holdings
Sectors
Countries
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +31.23% | +26.53% | +28.94% | +33.27% |
Max drawdown | -7.88% | -18.16% | -46.21% | -72.17% |
Max drawdown duration | 36d | 141d | 1095d | 1807d |
Time to recover | 28d | N/A | N/A | N/A |
Replication quality
Data as of May 29, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
What type of ETF is GNOM?
GNOM is a Passive ETF that provides exposure to Equity assets. It is managed by Global X.
What index does GNOM track?
GNOM tracks the Solactive Genomics Index - USD, aiming to replicate its performance through full replication.
What does GNOM invest in?
This ETF provides exposure to Equities. It is part of the segment: BioTech & Genomics.
What is the expense ratio of GNOM?
The total expense ratio (TER) of GNOM is 0.5%, representing the annual fee charged by the fund manager.
When was GNOM launched?
GNOM was launched on April 5, 2019, marking its entry into the ETF market.
Who is the issuer of GNOM?
GNOM is issued by Global X.
What is the AUM of GNOM?
As of June 12, 2026, GNOM manages $59.59 M, reflecting the total assets held in the fund.
How has GNOM performed recently?
As of June 12, 2026, GNOM delivered a return of 4.86% over the past month (1M performance), 12.44% over the past three months (3M), and 7.73% year-to-date (YTD).
What are the recent fund flows for GNOM?
As of June 12, 2026, GNOM has seen net flows of +$4M in the past month (1M flow) and +$4M year-to-date (YTD).
Does GNOM pay dividends?
As of June 12, 2026, GNOM has a trailing 12-month distribution yield of 1.27%.
How many holdings are in GNOM
As of April 30, 2026, GNOM holds 49 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is GNOM?
As of April 30, 2026, GNOM holds 49 securities, with 66.44% of its assets concentrated in its top 15 holdings.
What are the top holdings of GNOM?
As of April 30, 2026, GNOM holds a portfolio of 49 underlyings, with its largest positions including MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does GNOM invest in?
As of April 30, 2026, GNOM has its largest geographic exposures in USA.
What sectors or themes does GNOM focus on?
As of April 30, 2026, GNOM is primarily exposed to Health Care.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - New Autism-Impact ETF Launched
Defiance ETFs has launched the first ETF, $ASD, focused on the autism ecosystem, investing in companies that provide services, products, and research related to autism and neurodivergence.
ETF Trends
ETF Industry KPIs June 1, 2026
The ETF Industry saw 22 New Launches, 1 Ticker Change and 1 closure last week.
ETF Trends
ETF Industry KPIs May 20, 2026
The ETF Industry saw 44 New Launches, 3 Mutual Fund Conversions and 9 closures last week.
Asset TV
The ETF Show - Politics Becomes Investable Trade through ETFs
Dan Weiskopf, Senior Portfolio Manager at Tidal Financial Group spoke with the ETF Show about Subversive ETFs that help investors trade like politicians.
Browse all educational columns
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
